AstraZeneca

Breakthrough designation AstraZeneca’s severe asthma drug

https://pharmaphorum.com/news/astrazeneca-asthma-breakthrough/

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

AstraZeneca changes contractors as HQ delayed again

https://pharmaphorum.com/news/astrazeneca-changes-contractors-as-hq-delayed-again/

AstraZeneca to present the latest cardiovascular research

https://pharmaphorum.com/news/astrazeneca-presents-latest-cardio-research/

Drug firms fight US government’s Iraq corruption probe

https://pharmaphorum.com/news/drug-firms-fight-us-governments-iraq-corruption-probe/

Neurofibromatosis treatment granted orphan status by EMA

https://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/

Vertex and Alnylam orphan drugs set for EU approval

https://pharmaphorum.com/market-access-2/chmp-vertex-symkevi-alnylam-onpattro/

AZ suffers setback as NICE slaps restrictions on Fasenra

https://pharmaphorum.com/news/az-suffers-setback-as-nice-slaps-restrictions-on-fasenra/

AZ forges surprise R&D deal with virus gene therapy biotech

https://pharmaphorum.com/top-pharmaceutical-companies/astrazeneca/az-steps-avv-field-medimmune-4dmt/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search